Top Markets
#1 Akedo Akedo +57.11%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.98%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.56%
#6 τemplar τemplar +28.04%
#7 Ribbita by Virtuals Ribbita by Virtuals +19.92%
#8 Bitway Bitway +17.09%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.98%
#10 Cap Cap +16.13%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Braxia Scientific Corp. Braxia Scientific Corp.

Braxia Scientific Corp.

BRAX
Rang in Aktien #38350
Braxia Scientific Corp. is a medical research enterprise that runs clinics... Braxia Scientific Corp. is a medical research enterprise that runs clinics specializing in ketamine-based treatments for individuals facing depression and related conditions. The company further operates a network of multidisciplinary clinics dedicated to addressing a wide spectrum of mental health disorders. Beyond its clinical services, Braxia is actively engaged in research and development, striving to discover and commercialize novel pharmaceutical compounds and advanced delivery systems. Utilizing its intellectual property development platform, it focuses on the creation and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products. The firm's corporate headquarters are located in Toronto, Ontario.
Aktienkurs
$0.00366968
Zuletzt synchronisiert: 2024-08-02
Marktkapitalisierung
$1.04M
Veränderung (1 Tag)
0.54%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Braxia Scientific Corp. (BRAX)

Kategorie

Healthcare
P/B-Verhältnis für Braxia Scientific Corp. (BRAX)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Braxia Scientific Corp. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Braxia Scientific Corp. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE